Related Experiment Video
Updated: Sep 5, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
[Ureaplasma parvum arthritis affecting knee, hip, and sacroiliac joint]
Cecilie Hviid Christiansen1, Peter Doering2, Jurgita Samulioniené1
1Klinisk Mikrobiologisk Afdeling, Aalborg Universitetshospital.
Abstract:
In this case report a rare case of Ureaplasma parvum arthritis affecting the left knee, hip, and the sacroiliac joint in a 57-year-old woman is investigated. The patient was initially treated with intravenous piperacillin/tazobactam and later on meropenem with no clinical effect. After surgery of the hip and knee, tissue biopsies and synovial fluids were all culture negative. Eventually, Ureaplasma parvum was detected by 16S analysis, and the antibiotic regimen was changed to intravenous moxifloxacin. The patient improved and after four weeks the therapy was changed to lifelong oral therapy with moxifloxacin.
Insights
This case report details a rare instance of Ureaplasma parvum causing arthritis in a woman's knee, hip, and sacroiliac joint. Effective treatment involved moxifloxacin after initial antibiotics failed, highlighting a novel therapeutic approach.
Area of Science:
- Infectious Diseases
- Rheumatology
- Microbiology
Background:
- Ureaplasma parvum is a bacterium rarely associated with joint infections.
- Polyarticular arthritis can present diagnostic challenges, especially with negative initial cultures.
Observation:
- A 57-year-old woman presented with severe arthritis affecting the left knee, hip, and sacroiliac joint.
- Initial broad-spectrum antibiotic treatment (piperacillin/tazobactam, meropenem) was ineffective.
- Post-surgical tissue and synovial fluid cultures were negative for bacterial growth.
Findings:
- 16S ribosomal RNA (16S rRNA) gene sequencing identified Ureaplasma parvum in affected joint tissues.
- Intravenous moxifloxacin therapy led to significant clinical improvement.
- Long-term oral moxifloxacin was prescribed for sustained management.
Implications:
- This case underscores the importance of considering Ureaplasma parvum in refractory polyarticular arthritis, even with negative conventional cultures.
- 16S rRNA analysis is a valuable tool for diagnosing difficult-to-culture pathogens.
- Moxifloxacin demonstrates efficacy in treating Ureaplasma parvum-induced arthritis, suggesting a potential targeted therapeutic strategy.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Viruses of Archaea
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Knee Joint
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris...
Diversity of Protists I
Bacterial Phylum Spirochaetes

